Search results
Could This Bullish News Make Novavax a Hot Buy?
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. For people who prefer a more...
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
This Could Spell Bad News for Novavax
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) investors are likely feeling frustrated. First, they had to wait as the company delayed filing for an Emergency Use Authorization...
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Investor's Business Daily· 7 months agoNovavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 9 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Novavax Won a Nod From FDA Advisors. Now What?
Motley Fool· 2 years agoIt's the moment Novavax (NASDAQ: NVAX) and its investors have been waiting for. A U.S. Food and Drug Administration (FDA) advisory panel voted for the...
Novavax's COVID-19 vaccine rollout off to sluggish start with just 7,000 doses in arms
ABC News via Yahoo News· 2 years agoFollowing its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 2 months agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Novavax Is a Step Behind, Again. Should You Be Worried?
Motley Fool· 7 months agoIn the earliest days of the coronavirus vaccine race, Novavax (NASDAQ: NVAX) stood out as a...
